104 related articles for article (PubMed ID: 32710701)
1. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
[TBL] [Abstract][Full Text] [Related]
4. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
[TBL] [Abstract][Full Text] [Related]
5. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins.
Wang Y; Liu W; Xu Y; He X; Yuan Q; Luo P; Fan W; Zhu J; Zhang X; Cheng X; Jiang Y; Xu HE; Zhuang Y
Nat Chem Biol; 2023 Nov; 19(11):1351-1360. PubMed ID: 37169960
[TBL] [Abstract][Full Text] [Related]
6. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages.
Wu KC; Condon ND; Hill TA; Reid RC; Fairlie DP; Lim J
J Innate Immun; 2023; 15(1):468-484. PubMed ID: 36882040
[TBL] [Abstract][Full Text] [Related]
7. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
Ghosh M; Rana S
Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
[TBL] [Abstract][Full Text] [Related]
8. C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake
Silva de França F; Villas-Boas IM; Cogliati B; Woodruff TM; Reis EDS; Lambris JD; Tambourgi DV
Front Immunol; 2021; 12():652242. PubMed ID: 33936074
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors.
Yadav MK; Maharana J; Yadav R; Saha S; Sarma P; Soni C; Singh V; Saha S; Ganguly M; Li XX; Mohapatra S; Mishra S; Khant HA; Chami M; Woodruff TM; Banerjee R; Shukla AK; Gati C
Cell; 2023 Oct; 186(22):4956-4973.e21. PubMed ID: 37852260
[TBL] [Abstract][Full Text] [Related]
10. Anaphylatoxins and their corresponding receptors as potential drivers in cartilage calcification during osteoarthritis progression.
Ruths L; Huber-Lang M; Schulze-Tanzil G; Riegger J
Osteoarthritis Cartilage; 2024 May; 32(5):514-525. PubMed ID: 38242312
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of human and murine C5a anaphylatoxins.
Schatz-Jakobsen JA; Yatime L; Larsen C; Petersen SV; Klos A; Andersen GR
Acta Crystallogr D Biol Crystallogr; 2014 Jun; 70(Pt 6):1704-17. PubMed ID: 24914981
[TBL] [Abstract][Full Text] [Related]
12. Decoding anaphylatoxins: unveiling the molecular mechanisms of complement receptor activation and signaling.
Fernández FJ; Vega MC
Trends Biochem Sci; 2024 Apr; 49(4):280-282. PubMed ID: 38233283
[TBL] [Abstract][Full Text] [Related]
13. Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody.
Cyranka L; Mariegaard I; Skjødt MO; Bayarri-Olmos R; Mollnes TE; Garred P; Rosbjerg A
J Innate Immun; 2023; 15(1):836-849. PubMed ID: 37952515
[TBL] [Abstract][Full Text] [Related]
14. Conformational variants of the ternary complex of C5a, C5aR1, and G-protein.
Gupta PK; Singh A; Rana S
J Biomol Struct Dyn; 2024 Jan; ():1-16. PubMed ID: 38247266
[TBL] [Abstract][Full Text] [Related]
15. C5a-C5aR1 axis controls mitochondrial fission to promote podocyte injury in lupus nephritis.
Ye B; Chen B; Guo C; Xiong N; Huang Y; Li M; Lai Y; Li J; Zhou M; Wang S; Wang S; Yang N; Zhang H
Mol Ther; 2024 May; 32(5):1540-1560. PubMed ID: 38449312
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Characterization of a New Class of C5aR1 Antagonists Showing
Hubler F; Renneberg D; Siendt H; Stamm S; Hilpert K; Caroff E; Delahaye S; Froidevaux S; Murphy MJ
J Med Chem; 2024 Mar; 67(5):4100-4119. PubMed ID: 38482828
[TBL] [Abstract][Full Text] [Related]
17. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
Carvelli J; Demaria O; Vély F; Batista L; Chouaki Benmansour N; Fares J; Carpentier S; Thibult ML; Morel A; Remark R; André P; Represa A; Piperoglou C; ; ; Cordier PY; Le Dault E; Guervilly C; Simeone P; Gainnier M; Morel Y; Ebbo M; Schleinitz N; Vivier E
Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800
[TBL] [Abstract][Full Text] [Related]
18. Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.
Hernandez MX; Jiang S; Cole TA; Chu SH; Fonseca MI; Fang MJ; Hohsfield LA; Torres MD; Green KN; Wetsel RA; Mortazavi A; Tenner AJ
Mol Neurodegener; 2017 Sep; 12(1):66. PubMed ID: 28923083
[TBL] [Abstract][Full Text] [Related]
19. C5a/C5aR1 axis as a key driver promotes epithelial-to-mesenchymal transition in airway epithelial cells in silica nanoparticles-induced pulmonary fibrosis.
Zhou S; Wang Z; Gao L; Chen M; Duan Y; Zhou P; Liu Z; Wu C; Zhang J; Zhu Q
Int Immunopharmacol; 2023 Dec; 125(Pt B):111112. PubMed ID: 37948857
[TBL] [Abstract][Full Text] [Related]
20. Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.
Sommerfeld O; Medyukhina A; Neugebauer S; Ghait M; Ulferts S; Lupp A; König R; Wetzker R; Schulz S; Figge MT; Bauer M; Press AT
Mol Ther; 2021 Jan; 29(1):338-346. PubMed ID: 32966769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
